{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T19:30:36Z","timestamp":1770060636974,"version":"3.49.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T00:00:00Z","timestamp":1637107200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001732","name":"Danmarks Grundforskningsfond","doi-asserted-by":"publisher","award":["126"],"award-info":[{"award-number":["126"]}],"id":[{"id":"10.13039\/501100001732","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Medical Mycology"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.mycmed.2021.101228","type":"journal-article","created":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T11:51:33Z","timestamp":1637236293000},"page":"101228","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Pulmonary mucormycosis in the aftermath of critical COVID-19 in an immunocompromised patient: Mind the diagnostic gap"],"prefix":"10.1016","volume":"32","author":[{"given":"Cornelia Geisler","family":"Crone","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jannik","family":"Helweg-Larsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morten","family":"Steensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maiken Cavling","family":"Arendrup","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Helleberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mycmed.2021.101228_bib0001","doi-asserted-by":"crossref","DOI":"10.1007\/s00134-021-06449-4","article-title":"Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis","author":"Verweij","year":"2021","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.mycmed.2021.101228_bib0002","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.4103\/ijo.IJO_1565_21","article-title":"Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebral mucormycosis in 2826 patients in India - Collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC), Report 1","volume":"69","author":"Sen","year":"2021","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.mycmed.2021.101228_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2019.11.021","article-title":"A multicentre observational study on the epidemiology, risk factors, management and outcomes of mucormycosis in India","volume":"26","author":"Patel","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.mycmed.2021.101228_bib0004","doi-asserted-by":"crossref","DOI":"10.1111\/myc.13338","article-title":"COVID-19-associated mucormycosis: an updated systematic review of literature","author":"Pal","year":"2021","journal-title":"Mycoses"},{"key":"10.1016\/j.mycmed.2021.101228_bib0005","doi-asserted-by":"crossref","first-page":"E268","DOI":"10.3390\/jof6040268","article-title":"Introduction of a comprehensive diagnostic and interdisciplinary management approach in haematological patients with mucormycosis: a pre and post-intervention analysis","volume":"6","author":"Risum","year":"2020","journal-title":"J Fungi"},{"key":"10.1016\/j.mycmed.2021.101228_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2016.01.017","article-title":"EUCAST technical note on isavuconazole breakpoints for Aspergillus, itraconazole breakpoints for Candida and updates for the antifungal susceptibility testing method documents","volume":"22","author":"Arendrup","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.mycmed.2021.101228_bib0007","article-title":"CT Findings of COVID-19-associated Pulmonary Mucormycosis: a Case Series and Literature Review","author":"Garg","year":"2021","journal-title":"Radiology"},{"key":"10.1016\/j.mycmed.2021.101228_bib0008","first-page":"1","article-title":"Current Understanding in the Pathophysiology of SARS-CoV-2-Associated Rhino-Orbito-Cerebral Mucormycosis: a Comprehensive Review","author":"Jose","year":"2021","journal-title":"J Maxillofac Oral Surg"},{"key":"10.1016\/j.mycmed.2021.101228_bib0009","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1111\/myc.13365","article-title":"Is there an association between zinc and COVID-19-associated mucormycosis? Results of an experimental and clinical study","volume":"64","author":"Muthu","year":"2021","journal-title":"Mycoses"},{"key":"10.1016\/j.mycmed.2021.101228_bib0010","doi-asserted-by":"crossref","DOI":"10.1111\/dme.14547","article-title":"Impact of diabetes on COVID-19 and other infection: report from the 22nd Hong Kong diabetes and cardiovascular risk factors \u2013 east meets west symposium","author":"Luk","year":"2021","journal-title":"Diabet Med"},{"key":"10.1016\/j.mycmed.2021.101228_bib0011","doi-asserted-by":"crossref","first-page":"e405","DOI":"10.1016\/S1473-3099(19)30312-3","article-title":"Global guideline for the diagnosis and management of mucormycosis: an initiative of the European confederation of medical mycology in cooperation with the mycoses study group education and research consortium","volume":"19","author":"Cornely","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.mycmed.2021.101228_bib0012","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.bbrc.2021.05.058","article-title":"Recognition through GRP78 is enhanced in the UK, South African, and Brazilian variants of SARS-CoV-2; An in silico perspective","volume":"562","author":"Ibrahim","year":"2021","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.mycmed.2021.101228_bib0013","first-page":"505","article-title":"Effect of dexamethasone on unfolded protein response genes (MTJ1, Grp78, Grp94, CHOP, HMOX-1) in HEp2 cell line","volume":"50","author":"Duzgun","year":"2013","journal-title":"Indian J Biochem Biophys"},{"key":"10.1016\/j.mycmed.2021.101228_bib0014","doi-asserted-by":"crossref","first-page":"e149","DOI":"10.1016\/S1473-3099(20)30847-1","article-title":"Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM\/ISHAM consensus criteria for research and clinical guidance","volume":"21","author":"Koehler","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.mycmed.2021.101228_bib0015","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.idc.2006.06.009","article-title":"Non-culture-based diagnostics for opportunistic fungi","volume":"20","author":"Mennink-Kersten","year":"2006","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.mycmed.2021.101228_bib0016","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1080\/23744235.2019.1590632","article-title":"Correlation of fungal cultures from non-sterile sites and Galactomannan assay with the diagnosis of aspergillosis and mucormycosis based on sterile culture results and histopathologic findings","volume":"51","author":"Kim","year":"2019","journal-title":"Infect Dis"},{"key":"10.1016\/j.mycmed.2021.101228_bib0017","article-title":"Disseminated Mucormycosis with Positive Aspergillus Galactomannan","volume":"2018","author":"Kitmiridou","year":"2018","journal-title":"Case Rep Infect Dis"},{"key":"10.1016\/j.mycmed.2021.101228_bib0018","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2021.26.23.2100510","article-title":"Case series of four secondary mucormycosis infections in COVID-19 patients, the Netherlands, December 2020 to May 2021","volume":"26","author":"Buil","year":"2021","journal-title":"Eurosurveillance"},{"key":"10.1016\/j.mycmed.2021.101228_bib0019","doi-asserted-by":"crossref","first-page":"708","DOI":"10.3390\/jof7090708","article-title":"Mucormycosis in CAPA, a possible fungal super-infection","volume":"7","author":"Saltini","year":"2021","journal-title":"J Fungi"},{"key":"10.1016\/j.mycmed.2021.101228_bib0020","doi-asserted-by":"crossref","DOI":"10.1007\/s11046-021-00584-8","article-title":"Epidemiology and pathophysiology of COVID-19-associated mucormycosis: India versus the rest of the world","author":"Muthu","year":"2021","journal-title":"Mycopathologia"}],"container-title":["Journal of Medical Mycology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1156523321001190?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1156523321001190?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T05:21:43Z","timestamp":1761110503000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1156523321001190"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S1156523321001190"],"URL":"https:\/\/doi.org\/10.1016\/j.mycmed.2021.101228","relation":{},"ISSN":["1156-5233"],"issn-type":[{"value":"1156-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pulmonary mucormycosis in the aftermath of critical COVID-19 in an immunocompromised patient: Mind the diagnostic gap","name":"articletitle","label":"Article Title"},{"value":"Journal of Medical Mycology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mycmed.2021.101228","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Masson SAS on behalf of SFMM.","name":"copyright","label":"Copyright"}],"article-number":"101228"}}